HbA1c and Peripheral Sensory Loss in Relation to Diabetic Foot Screening Findings
DOI:
https://doi.org/10.22487/2kep6r95Keywords:
Diabetic foot, Glycated hemoglobin, Peripheral neuropathy, Screening, Sensory lossAbstract
complications and care needs among people with diabetes. Objectives: To examine associations of HbA1c and peripheral sensory loss with abnormal foot screening findings among Persadia members at PKU Muhammadiyah Gamping Hospital. Methods: This quantitative cross sectional study included 36 participants selected by total sampling. HbA1c measurement, 10 g monofilament examination, and standardized foot observation were performed. HbA1c was categorized as <7% or >/7%. Frequencies, contingency tables, odds ratios with 95% confidence intervals, and two sided Fisher exact tests were analyzed. Results: Twenty seven participants had HbA1c <7%, and 13 had abnormal foot screening findings. Abnormal findings occurred in 4 of 9 participants with HbA1c >/7% and 9 of 27 with HbA1c <7% (OR 1.60; 95% CI 0.34–7.46; p=0.693). Recalculation of the reported sensory loss table yielded OR 3.09 (95% CI 0.71–13.47; p=0.153), although the sensory loss table requires reconciliation with the descriptive neuropathy counts. Conclusions: Neither HbA1c category nor peripheral sensory loss showed a statistically significant association with abnormal foot screening findings. Glycemic monitoring and standardized foot assessment remain complementary components of diabetes care.
Downloads
References
1. International Diabetes Federation. IDF Diabetes Atlas. 11th ed. International Diabetes Federation; 2025. https://diabetesatlas.org/resources/idf-diabetes-atlas-2025/
2. World Health Organization. Diabetes. Published November 14, 2024. Accessed October 1, 2026. https://www.who.int/news-room/fact-sheets/detail/diabetes
3. Hossain MJ, Al Mamun M, Islam MR. Diabetes mellitus, the fastest growing global public health concern: early detection should be focused. Health Sci Rep. 2024;7(3):e2004. doi:10.1002/hsr2.2004
4. Armstrong DG, Tan TW, Boulton AJM, Bus SA. Diabetic foot ulcers: a review. JAMA. 2023;330(1):62–75. doi:10.1001/jama.2023.10578
5. Feldman EL, Callaghan BC, Pop Busui R, et al. Diabetic neuropathy. Nat Rev Dis Primers. 2019;5(1):41. doi:10.1038/s41572-019-0092-1
6. American Diabetes Association Professional Practice Committee for Diabetes. 12. Retinopathy, neuropathy, and foot care: Standards of Care in Diabetes 2026. Diabetes Care. 2026;49(suppl 1):S261–S276. doi:10.2337/dc26-S012
7. Schaper NC, van Netten JJ, Apelqvist J, et al. Practical guidelines on the prevention and management of diabetes related foot disease (IWGDF 2023 update). Diabetes Metab Res Rev. 2024;40(3):e3657. doi:10.1002/dmrr.3657
8. Bus SA, Sacco ICN, Monteiro Soares M, et al. Guidelines on the prevention of foot ulcers in persons with diabetes (IWGDF 2023 update). Diabetes Metab Res Rev. 2024;40(3):e3651. doi:10.1002/dmrr.3651
9. Handayani DS, Vitayani S, Harahap MW, Gani AB, Nur MJ. Analysis of complications in type 2 diabetes mellitus patients at Ibnu Sina Hospital in 2023. Healthy Tadulako J. 2025;11(2):300–306. doi:10.22487/htj.v11i2.1664
10. American Diabetes Association Professional Practice Committee for Diabetes. 6. Glycemic goals, hypoglycemia, and hyperglycemic crises: Standards of Care in Diabetes 2026. Diabetes Care. 2026;49(suppl 1):S132–S149. doi:10.2337/dc26-S006
11. American Diabetes Association Professional Practice Committee for Diabetes. 13. Older adults: Standards of Care in Diabetes 2026. Diabetes Care. 2026;49(suppl 1):S277–S296. doi:10.2337/dc26-S013
12. Stratton IM, Adler AI, Neil HAW, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321(7258):405–412. doi:10.1136/bmj.321.7258.405
13. Pop Busui R, Boulton AJM, Feldman EL, et al. Diabetic neuropathy: a position statement by the American Diabetes Association. Diabetes Care. 2017;40(1):136–154. doi:10.2337/dc16-2042
14. Wang F, Zhang J, Yu J, et al. Diagnostic accuracy of monofilament tests for detecting diabetic peripheral neuropathy: a systematic review and meta analysis. J Diabetes Res. 2017;2017:8787261. doi:10.1155/2017/8787261
15. Crawford F, Cezard G, Chappell FM, et al. A systematic review and individual patient data meta analysis of prognostic factors for foot ulceration in people with diabetes: the international research collaboration for the prediction of diabetic foot ulcerations (PODUS). Health Technol Assess. 2015;19(57):1–210. doi:10.3310/hta19570
16. Hardayanti KR, Rau MJ, Arifuddin A. Pengaruh perilaku pengendalian diabetes melitus terhadap kadar gula darah pasien di Rumah Sakit Umum Anutapura Kota Palu. Healthy Tadulako J. 2018;4(3):61–66. doi:10.22487/htj.v4i3.76
17. Putri RS, Isnaini N, Purwito D, Aniarti RP. Overview of 3J diet compliance in type 2 diabetes mellitus patients at the Purwokerto Timur II Community Health Center. Healthy Tadulako J. 2026;12(3):433–443. doi:10.22487/msapr842
18. Manggasa DD, Rantesigi N, Nurjayanti N. Pengaruh edukasi perkembangan luka berbasis foto terhadap kecemasan pasien ulkus diabetik. Healthy Tadulako J. 2024;10(2):173–179. doi:10.22487/htj.v10i2.945
19. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med. 2007;4(10):e296. doi:10.1371/journal.pmed.0040296
20. Sacks DB, Kirkman MS, Little RR. Point of care HbA1c in clinical practice: caveats and considerations for optimal use. Diabetes Care. 2024;47(7):1104–1110. doi:10.2337/dci23-0040
21. Lang TA, Altman DG. Basic statistical reporting for articles published in biomedical journals: the Statistical Analyses and Methods in the Published Literature or the SAMPL guidelines. Int J Nurs Stud. 2015;52(1):5–9. doi:10.1016/j.ijnurstu.2014.09.006
22. Purwanti OS, Nursalam N, Pandin MGR. Early detection of diabetic neuropathy based on health belief model: a scoping review. Front Endocrinol (Lausanne). 2024;15:1369699. doi:10.3389/fendo.2024.1369699
23. Zilliox LA, Russell JW. Physical activity and dietary interventions in diabetic neuropathy: a systematic review. Clin Auton Res. 2019;29(4):443–455. doi:10.1007/s10286-019-00607-x
24. Dorresteijn JAN, Kriegsman DMW, Assendelft WJJ, Valk GD. Patient education for preventing diabetic foot ulceration. Cochrane Database Syst Rev. 2014;(12):CD001488. doi:10.1002/14651858.CD001488.pub5
25. Bus SA, Waaijman R, Arts M, et al. Effect of custom made footwear on foot ulcer recurrence in diabetes: a multicenter randomized controlled trial. Diabetes Care. 2013;36(12):4109–4116. doi:10.2337/dc13-0996
26. Bus SA, Aan de Stegge WB, van Baal JG, Busch Westbroek TE, Nollet F, van Netten JJ. Effectiveness of at home skin temperature monitoring in reducing the incidence of foot ulcer recurrence in people with diabetes: a multicenter randomized controlled trial (DIATEMP). BMJ Open Diabetes Res Care. 2021;9(1):e002392. doi:10.1136/bmjdrc-2021-002392
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Auliya Rosyida Anwar, Adi Sucipto, Desty Ervira Puspaningtyas, Silvia Dewi Styaningrum, Puspita Mardika, Much Maschun Syarifun
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
